Residual IDH1-Mutant Tumor Cell Quantification Study
Clinical trial NCT07219199 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07219199
- Sponsor
- NYU Langone Health
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2030-12-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.